Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series.

MLA

Iwasawa, Tomohiro, et al. “Characterizing Cyclin-Dependent Kinase 12(CDK12)-Altered Aggressive Prostate Cancer: A Twelve-Case Series.” International Journal of Clinical Oncology, vol. 27, no. 12, Dec. 2022, pp. 1867–73. EBSCOhost, https://doi.org/10.1007/s10147-022-02248-z.

APA

Iwasawa, T., Kosaka, T., Yasumizu, Y., Hongo, H., Yanai, Y., Baba, Y., Matsumoto, K., Nakamura, K., Nishihara, H., & Oya, M. (2022). Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series. International Journal of Clinical Oncology, 27(12), 1867–1873. https://doi.org/10.1007/s10147-022-02248-z

Chicago

Iwasawa, Tomohiro, Takeo Kosaka, Yota Yasumizu, Hiroshi Hongo, Yoshinori Yanai, Yuto Baba, Kazuhiro Matsumoto, Kohei Nakamura, Hiroshi Nishihara, and Mototsugu Oya. 2022. “Characterizing Cyclin-Dependent Kinase 12(CDK12)-Altered Aggressive Prostate Cancer: A Twelve-Case Series.” International Journal of Clinical Oncology 27 (12): 1867–73. doi:10.1007/s10147-022-02248-z.